Could a new nanotechnology make personalized cancer vaccines a reality?

A chemistry—medicine collaboration has given rise to a new nanotechnology that holds promise for personalized cancer vaccines. Personalized cancer vaccines may be one step closer to reality following new multidisciplinary research from the Lin (chemistry) and Weichselbaum (medicine) labs at the University of Chicago (IL, USA). The researchers developed a two-pronged approach using nanoscale metal-organic frameworks (nMOFs) that aim to provide both local and systemic treatment in one therapeutic and activate both the innate and adaptive immune response. nMOFs comprise repeating units in a lattice formation, which makes them ideal for delivering anti-cancer drugs. They also generate free radicals within...